U.S. Software Stock News

In late July 2026, Qorvo reported first-quarter fiscal 2027 results showing sales of US$784.8 million versus US$818.78 million a year earlier, with net income rising to US$85.8 million from US$25.59 million and diluted EPS increasing to US$0.96 from US$0.27. Despite reporting lower revenue and completing a share repurchase of 17,597,000 shares for US$1.58 billion since November 2022, Qorvo significantly increased profitability year over year, highlighting a shift toward more efficient...

In July 2026, VEON Ltd. reported its second-quarter 2026 results, with sales rising to US$1,271 million from US$1,087 million a year earlier, while net income fell to US$122 million from US$595 million and basic earnings per share from continuing operations dropped to US$1.75 from US$8.5. At the same time, VEON raised its full-year 2026 revenue growth guidance to a 15% to 18% year-over-year increase, up from its prior 11% to 14% range, signaling greater confidence in its top-line outlook...

Prosperity Bancshares (PB) recently reported second quarter 2026 results that included higher net interest income and net income compared with a year earlier. The update also showed lower net charge-offs and progress on loan resolution activity. See our latest analysis for Prosperity Bancshares. Prosperity Bancshares' latest earnings, lower net charge-offs and ongoing acquisition activity sit against a share price of $73.34, with a 90 day share price return of 8.23% and a 1 year total...

Why PACS Group Stock Is Back on Investors’ Radar PACS Group (PACS) has attracted fresh attention after reporting its second quarter 2026 results and raising full year revenue and adjusted EBITDA guidance, alongside progress on the Eduro Healthcare facility acquisitions. See our latest analysis for PACS Group. The earnings beat and upgraded 2026 guidance have coincided with stronger trading in PACS Group, with a 7 day share price return of 8.88% and year to date share price return of 22.63%...

Reports of burnout inside big AI and automation firms are clashing with promises of effortless productivity, and that gap is where investors should pay attention. Stress, reshuffles, and long hours can unsettle some companies while creating openings for others that handle the pressure better. This article unpacks that tension and highlights 3 stocks from our AI and Automation Technology screener that appear positively exposed to the current news flow. The 3 stocks below are just a starting...

Earnings event puts Expand Energy under closer investor review Expand Energy (EXE) reported second quarter 2026 results that combined lower quarterly revenue and net income with higher production, stronger six month earnings, a reaffirmed output outlook, continued buybacks, and an unchanged dividend. This mix of data points gives you several angles to assess the stock, from cash generation and capital returns to how management is approaching growth in its natural gas focused portfolio. See...

With July inflation data expected to show a small CPI rebound and mixed signals on future Fed moves, many investors are quietly rethinking where they want to sit on the risk spectrum. Defensive sectors like healthcare and consumer staples often come back into focus when inflation and rates feel uncertain. This article walks through three large cap stocks exposed to these inflation trends and explains why some investors are watching them closely now. The three stocks highlighted below are only...

Hess Midstream LP has reported its second-quarter 2026 results, with revenue of US$399.0 million and net income of US$96.4 million, and has issued third-quarter net income guidance of US$165.0 million to US$175.0 million while maintaining its full-year 2026 net income outlook of US$650.0 million to US$700.0 million. An interesting angle for investors is that Hess Midstream’s net income rose year over year despite slightly lower revenue, suggesting some operational or cost efficiency...

Why Obsidian Therapeutics Stock Is Back in Focus After New Trial Milestone Obsidian Therapeutics (OBX) is drawing fresh attention after enrolling the first patient in a registration enabling cohort of its Phase 1/2 Agni-01 trial for amsoki-cel in advanced melanoma. See our latest analysis for Obsidian Therapeutics. The trial milestone comes after a sharp rebound in Obsidian Therapeutics’ share price, with a 1 day share price return of 27.27% and a year to date share price return of 435.22%...

Columbia Financial, Inc. recently reported second-quarter 2026 results showing higher net interest income of US$62.92 million and net income of US$14.49 million versus the prior year, while affirming a US$0.05 quarterly dividend and posting lower net charge-offs of US$2.0 million. Together with a new shelf registration for common stock tied to its ESOP and board expansion following the Northfield Bancorp acquisition, these updates highlight how Columbia Financial is balancing growth...

In the past week, Vontier Corporation reported second-quarter 2026 results showing sales of US$756.7 million and net income of US$27.4 million, alongside updated full-year and third-quarter sales guidance, and confirmed it has completed a US$1.17 billion share repurchase program launched in 2021. While quarterly earnings softened year on year, the completion of a buyback covering almost one-quarter of shares points to a significant shift in Vontier’s capital allocation and balance between...

In early August 2026, ADW Capital Management publicly challenged Driven Brands Holdings Inc.’s Board and major shareholder Roark Capital Group, criticizing the unanimous rejection of its all-cash US$18.00 per share bid and demanding an immediate strategic review, including potential whole-company or segment sales, while highlighting concerns over governance, delayed filings, and shareholder treatment. ADW’s threat that minority investors may pursue legal remedies, coupled with its push for...

Boise Cascade Company recently reported past second-quarter 2026 results showing sales of US$1,831.34 million and net income of US$57.34 million, alongside an expanded nationwide distribution agreement under which its Building Materials Distribution division will become the sole U.S. distributor of James Hardie’s full exterior product portfolio from July 31, 2026. The combination of this exclusive James Hardie partnership, a completed share repurchase of 2,377,455 shares for US$178.64...

In early August 2026, Sabra Health Care REIT, Inc. reported its second-quarter and first-half results, with revenue increasing to US$235.87 million for the quarter and US$457.62 million for the half-year, while moving from net income a year earlier to a net loss of US$25.2 million in the quarter and lower net income of US$15.68 million year to date. Alongside this mixed earnings picture, the company reaffirmed a quarterly dividend of US$0.30 per share payable on August 31, 2026,...

Q2 results highlight revenue growth and lower profitability Radware (NasdaqGS:RDWR) drew investor focus after reporting second quarter 2026 results on 29 July, with higher sales than a year earlier and lower net income, alongside fresh revenue guidance for the third quarter. The company reported Q2 sales of US$82.28 million, compared with US$74.11 million for the same period in 2025. Net income for the quarter was US$1.71 million, compared with US$4.22 million a year earlier. Basic earnings...

In early August 2026, Entergy Corporation completed two US$750 million fixed‑to‑floating rate junior subordinated debenture offerings due 2056 and 2058, alongside announcing additional fixed‑rate junior subordinated debentures and declaring a US$0.64 quarterly dividend. These long‑dated, unsecured and callable hybrid bonds, combined with second‑quarter revenue and net income increases versus last year, highlight how Entergy is balancing capital structure flexibility with ongoing earnings...

Klarna Group stock has fallen 31.3% year to date, yet the current market multiples still screen as undervalued. This leaves investors weighing whether the weaker share price already reflects the main risks. The year to date decline of 31.3% suggests sentiment has cooled and the market is now asking harder questions about Klarna Group's earnings power and balance of risks. Future revenue growth and cash flow conversion can support the current valuation, while any pressure on profitability or...

Seacoast Banking Corporation of Florida has reported its second-quarter 2026 results, with net interest income of US$180.4 million and net income of US$59.54 million, alongside higher basic and diluted earnings per share from continuing operations than a year earlier, and modestly higher net charge-offs of US$3,199,000. Over the first half of 2026, earnings per share were roughly flat despite higher net income, and the company completed a share repurchase of 1,069,308 shares for US$33.45...

Right now trade rules, export controls and compliance crackdowns are reshaping how money flows through defense and aerospace stocks. Shifts at the FCC, BIS, courts and the DOJ are changing who can sell what, to whom and on what terms. That is creating fresh winners and new risks. This article walks through three US Defense and Aerospace Stocks screener picks that appear well positioned for the current wave of policy change. The stocks highlighted below are just a sample, and the full screen...

Traders rushed into National Energy Services Reunited on Monday, sending the stock up 23.3% to US$35.79 in the first full session after earnings. The move came after NESR posted record Q2 2026 results, headlined by US$520.8m in revenue and US$106.2m in adjusted EBITDA, which translated into an adjusted EPS of US$0.44. The market is treating this as a clean upside surprise. The real question for you is whether this surge simply catches up with the fundamentals or whether it starts to price in...

Guardian Pharmacy Services (GRDN) drew investor attention after releasing second quarter 2026 results that showed higher sales and net income compared with a year earlier. The company also raised full year revenue guidance. See our latest analysis for Guardian Pharmacy Services. The latest earnings release and raised guidance have come after a strong period for Guardian Pharmacy Services, with a year to date share price return of 40.43% and a 1 year total shareholder return of 108.60%. This...

Energy stocks are back in the spotlight as the US Israeli attack on Iran and fresh uncertainty in the Strait of Hormuz put supply routes, shipping costs and risk premiums under scrutiny. For investors, that kind of shock can quickly reshape where capital flows and which companies gain or lose market confidence. This article profiles 3 large, established energy related stocks that appear particularly exposed to these headlines and explains why that might matter for a diversified portfolio. The...

nLIGHT's share price has risen sharply over the past few years, yet its valuation checks currently lean expensive, which leaves investors weighing a strong share price record against a relatively weak value score. Over the past 3 years, nLIGHT has delivered a return of around 3.6x, which puts recent share price weakness into the context of a very strong longer term move. Expectations for nLIGHT's revenue growth and margin progression can support a higher valuation. However, any...

Global markets are being shaken by shifting economic policies and fresh signals from central banks, which is leaving many investors unsure about where to look next for reliable dividend income. Yet moments like this often separate temporary noise from long term opportunity. This article highlights 3 global blue chip dividend stocks that are closely tied to the recent news and explains why they might deserve a closer look if you care about income, resilience and staying invested with...